- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05944900
Study Comparing the Efficacy of Peripherally Inserted Central Catheter (PICC) Placement With the Addition of Cyanoacrylate Glue Versus PICC Placement Alone in Patients With Cancer. (PICCandGLUE)
Randomized, Prospective, Single-center Trial Comparing the Efficacy of Peripherally Inserted Central Catheter (PICC) Placement With the Addition of Cyanoacrylate Glue Versus PICC Placement Alone (Without Glue) in Patients With Cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Peripherally Inserted Central Catheters (PICCs) are a form of vascular access inserted percutaneously into a vein, usually in the arm, with the distal end at the atrio cava junction (between the superior vena cava and the right atrium). They may be used for a prolonged period or for several days, repeatedly over time (as is the case for certain chemotherapies, parenteral nutrition or long-term intravenous treatments).
Their placement requires aseptic surgical conditions, and a team trained in the procedure, sometimes grouped together in a Vascular Access Unit (UAV).
A PICC is inserted by puncturing the skin and subcutaneous tissues, and securing the catheter with a "Statlock" type stabilizer. The catheter exit point must be covered, at a minimum by a sterile occlusive dressing with a transparent semi-permeable membrane, otherwise referred to as a "transparent dressing".
According to available data, tissue puncture results in bleeding at the puncture site in 25% to 40% of procedures. This bleeding necessitates the application of a sterile compress prior to covering with a transparent dressing. The skin puncture site (also known as the catheter exit point) requires the dressing to be repeated on D1 after insertion.
To sum up:
- If there is no bleeding, there is no need to apply a compress, and the dressing can be changed on D8 after application;
- In the presence of bleeding, a compress is applied and dressing change is mandatory on D1 after application.
PICC placement combined with the use of cyanoacrylate glue would reduce the risk of bleeding, and therefore the need to use of a compress, compared with a standard procedure (without the use of glue).
On this basis, the investigators propose to conduct a randomized, prospective, single-center trial comparing the efficacy of peripherally inserted central catheter (PICC) with the addition of cyanoacrylate glue versus PICC placement alone (without glue) in patients with cancer.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Grégoire WALLON, MD
- Phone Number: +33 04 78 78 27 53
- Email: gregoire.wallon@lyon.unicancer.fr
Study Locations
-
-
-
Lyon, France
- Recruiting
- Centre Léon Bérard
-
Contact:
- Grégoire WALLON, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female, 18 years of age or older on the date of signature the informed consent form
- Patient with a histological diagnosis of cancer
- Indication for central line chemotherapy or immunotherapy
- Placement of a single-lumen PICC in the non-tunneled upper limb planned on an ambulatory basis at the Centre
- Planned duration of PICC use > 30 days
- Dated and signed informed consent, indicating that the patient has been informed of all relevant aspects of the study prior to inclusion;
- Patient covered by a health insurance plan
Exclusion Criteria:
- Patient already included in the study ;
- Patient with known allergy to cyanoacrylates, Violet D&C or formaldehyde;
- Patient not reachable by telephone ;
- Patient under guardianship;
- Patient does not speak French.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PICC placement according to standard practice + cyanoacrylate glue
PICC placement will be performed according to standard practice (Safe Insertion of PICC protocol (SIP2) steps). The catheter will be secured by the Statlock system. Cyanoacrylate glue will be applied on the catheter exit point in accordance with the instructions for use. A transparent dressing will be applied, with a compress in the event of bleeding. |
The wound must be positioned in a horizontal plane, and the glueapplied uniformly overhanging the wound. Cyanoacrylate glue is contraindicated when adhesion cannot be achieved. Cyanoacrylate glue should be applied in accordance with the instructions for use. Wound-closing properties are only fully achieved once the first layer has fully polymerized. This depends on skin type, skin hydration and ambient humidity. If a second layer is applied, the polymerization time is extended accordingly. |
No Intervention: PICC placement according to standard practice
PICC placement will be performed according to standard practice (Safe Insertion of PICC protocol (SIP2) steps). The catheter will be secured by the Statlock system. A transparent dressing will be applied, with a compress in the event of bleeding. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of patients with successful PICC placement
Time Frame: Hour 0
|
Success is defined by the possibility of using a dressing without compression at application (at hour 0), i.e. without bleeding after the defined compression time.
|
Hour 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of dressing changes within one hour
Time Frame: Up to hour 1
|
Proportion of patients requiring dressing changes at the CLB within one hour of the end of procedure
|
Up to hour 1
|
Proportion of dressing changes before day 8
Time Frame: Up to day 8
|
Proportion of patients requiring dressing changes (home nursing/home care/home hospitalization) in the medium term (day 8)
|
Up to day 8
|
Proportion of dressing changes before day 30
Time Frame: Up to day 30
|
Proportion of patients requiring dressing changes (home nursing/home care/home hospitalization) in the medium term (day 30)
|
Up to day 30
|
Incidence of PICC removal before day 30
Time Frame: Up to day 30
|
Incidence of PICC removal for any reason within 30 days following placement.
|
Up to day 30
|
Incidence of PICC-related complications before day 30
Time Frame: Up to day 30
|
Incidence of PICC-related complications (infection, thrombotic event, obstruction, displacement requiring PICC replacement or not) in the 30 days following placement.
|
Up to day 30
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Grégoire WALLON, MD, Centre Léon Bérard
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ET23-122
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on Cyanoacrylate glue application
-
Kuopio University HospitalNorth Karelia Central Hospital; Paijat-Hame Hospital DistrictCompleted
-
Children's Hospital of Eastern OntarioThe Physicians' Services Incorporated FoundationCompleted
-
Clinique PasteurCompleted
-
Hams Hamed AbdelrahmanActive, not recruiting
-
Yale UniversityCompletedBasal Cell Carcinoma | Squamous Cell CarcinomaUnited States
-
Ottawa Hospital Research InstituteUnknownSurgical Wound Infection
-
Centre Hospitalier Universitaire de NiceAssistance Publique Hopitaux De Marseille; Fondation Lenval; Centre Hospitalier...Completed
-
University Hospital OstravaRecruitingAdult Patients With Mid-term or Long-term Venous AccessCzechia
-
Columbia UniversityCompletedCentral Line Complication | Neonatal DiseaseUnited States
-
Tongji HospitalRecruitingPortal Hypertension | Gastroesophageal Varices | HypersplenismChina